In an era of rapid technological breakthroughs, the incorporation of artificial intelligence (AI) into numerous industries is transforming the way in which we all work. AI has been shown to be a valuable tool for automating mundane processes and analyzing large datasets. However, as we embrace its potential, we must also address the cybersecurity threats […]
With a sense of honor and the common good, last month some scammers “promised to refrain” from attacking healthcare operations during the COVID-19 pandemic. Unfortunately, some people believed them! I get it. This virus impacts every one of us. We all would like to believe that, in this current environment, people will step up and […]
Science fiction has always been the white board for technological innovation. Think of all the books and/or movies you have digested. How many times have you said, “well, that will never happen?” And looking back, how many futuristic concepts have eventually become reality? More than you may realize. Let me give you a few fun […]
In light of the current pandemic and increased cyber threats as outlined here by the Harvard Business Review, a VPN might be a worthwhile investment in the fight against crime, especially now that many are on lockdown and are working from home. I’m sure most of you have heard the term VPN or Virtual Private […]
As the coronavirus spreads around the globe, unfortunately so do cyber-criminal attacks. Cyber criminals see this as a golden opportunity to capitalize. Hackers leverage the panic, confusion, and misinformation to transmit malware, breach computer networks, set up malicious websites, and launch social engineering attacks. Early on in the coronavirus pandemic, the Cybersecurity and Infrastructure Security […]
February 14, 2020 could be called a red letter day in the world of Rx-to-OTC switch. After a long period of drought, FDA announced that they have approved the Rx-to-OTC switch of three prescription drugs. Please see the announcement here. The three drugs are: Voltaren Arthritis Pain (diclofenac sodium topical gel, 1%) for the temporary […]
FDA has announced the 12th Annual FDA Sentinel Public Workshop on April 20-21, 2020. (Please go here for the details.) The Sentinel System is the largest multi site patient safety database in the world, and includes the Active Post-marketing Risk Identification and Analysis (ARIA) system mandated by Congress in the US Food and Drug Administration […]
February 3, 2020 was the last day to comment on the Food and Drug Administration’s (FDA) notice in the Federal Register on the Novel Excipient Review Program Proposal; Request for Information and Comments (here), which we reported on in a previous blog post (here). In this notice, the FDA had proposed a pilot program related […]
Recently, FDA has posted (here) that Metformin, from several sources, tested by FDA showed that the levels of N-nitroso-dimethylamine (NDMA) in the drug are below the levels of detection (here). Great news! NDMA belongs to the nitrosamine family, and is one of the well-known animal carcinogens and a suspected human carcinogen. The nitrosamines, including NDMA, […]
(Westbury, NY – November 2019) Spanning approximately 120 minutes, part of the executive team from Lachman Consultant Services, Inc. (“Lachman Consultants”) guided 45 young professional engineers and chemists through an introduction to current Good Manufacturing Practices (“cGMP”) during ISPE’s 2019 Annual Meeting. As a leading provider of expert compliance, regulatory affairs and technical services to […]
